Hims & Hers Health PE Ratio 2020-2024 | HIMS
Current and historical p/e ratio for Hims & Hers Health (HIMS) from 2020 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Hims & Hers Health PE ratio as of November 22, 2024 is 134.17.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Hims & Hers Health PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-11-21 | 24.15 | 54.89 | |
| 2024-09-30 | 18.42 | $0.44 | 41.86 |
| 2024-06-30 | 20.19 | $0.08 | 252.38 |
| 2024-03-31 | 15.47 | $-0.01 | 0.00 |
| 2023-12-31 | 8.90 | $-0.11 | 0.00 |
| 2023-09-30 | 6.29 | $-0.17 | 0.00 |
| 2023-06-30 | 9.40 | $-0.22 | 0.00 |
| 2023-03-31 | 9.92 | $-0.29 | 0.00 |
| 2022-12-31 | 6.41 | $-0.32 | 0.00 |
| 2022-09-30 | 5.58 | $-0.42 | 0.00 |
| 2022-06-30 | 4.53 | $-0.41 | 0.00 |
| 2022-03-31 | 5.33 | $-0.36 | 0.00 |
| 2021-12-31 | 6.55 | $-0.62 | 0.00 |
| 2021-09-30 | 7.54 | $-0.54 | 0.00 |
| 2021-06-30 | 10.89 | $-0.46 | 0.00 |
| 2021-03-31 | 13.23 | $-0.41 | 0.00 |
| 2020-12-31 | 14.60 | $-0.07 | 0.00 |
| 2020-09-30 | 11.75 | 0 | 0.00 |
| 2020-06-30 | 10.17 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $5.276B | $0.872B |
| Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $8.263B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.580B | 174.01 |
| Enovis (ENOV) | United States | $2.580B | 17.49 |
| Privia Health (PRVA) | United States | $2.530B | 210.80 |
| IRhythm Technologies (IRTC) | United States | $2.313B | 0.00 |
| Azenta (AZTA) | United States | $2.227B | 111.05 |
| Omnicell (OMCL) | United States | $2.043B | 66.83 |
| Clover Health Investments (CLOV) | United States | $1.684B | 0.00 |
| 10x Genomics (TXG) | United States | $1.609B | 0.00 |
| Schrodinger (SDGR) | United States | $1.484B | 0.00 |
| Phreesia (PHR) | United States | $1.098B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.701B | 0.00 |
| Standard BioTools (LAB) | United States | $0.603B | 0.00 |
| Talkspace (TALK) | United States | $0.559B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.518B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.491B | 85.00 |
| Health Catalyst (HCAT) | United States | $0.466B | 0.00 |
| Pulmonx (LUNG) | United States | $0.254B | 0.00 |
| TruBridge (TBRG) | United States | $0.239B | 69.61 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.205B | 0.00 |
| American Well (AMWL) | United States | $0.123B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.115B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.077B | 0.00 |
| HeartBeam (BEAT) | United States | $0.075B | 0.00 |
| 111 (YI) | China | $0.052B | 0.00 |
| CareCloud (CCLD) | United States | $0.046B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.040B | 0.00 |
| Zepp Health (ZEPP) | China | $0.038B | 0.00 |
| Movano (MOVE) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.010B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |